UPDATE 1-New shingles vaccine shines as currency hits GSK earnings
April 25, 2018 at 07:38 AM EDT
LONDON, April 25 (Reuters) - Drugmaker GlaxoSmithKline reported a 2 percent fall in both sales and earnings in the first quarter on Wednesday as a stronger pound offset a promising start for its new shingles vaccine Shingrix.
